leucémie aigüe myéloïde et syndromes myélodysplasiques liés aux inhibiteurs de la topoisomérase II
A subgroup of therapy-related myeloid neoplasms (t-MN), associated with treatment of an unrelated neoplastic disease with cytotoxic agents, like etoposide, doxorubicin, daunorubicin and others. The neoplastic cells often show rearrangements involving
SNOMEDCT-BE (disorder) / 766046007
SNOMEDCT-BE (t-MN), associated with treatment of an unrelated neoplastic disease with cytotoxic agents, like etoposide, doxorubicin, daunorubicin and others. The neoplastic cells often show rearrangements involving / 766046007
